Last Updated: 09/12/07
Daniel Sullivan, M.D.
Former Associate Director
Cancer Imaging Program
Daniel Sullivan, M.D., has had a distinguished career in the field of radiology, with more than 70 publications in peer-reviewed journals. His areas of clinical and research expertise are nuclear medicine and breast imaging, and he holds certifications in diagnostic and nuclear radiology from the American Board of Radiology.
Dr. Sullivan joined the Cancer Imaging Program as its associate director in 1997. He currently heads the NCI-Food and Drug Administration (FDA) Interagency Oncology Task Force, NCI-Centers for Medicare & Medicaid Services (CMS) Interagency Task Force Imaging Subcommittee and the NCI Imaging Integration and Implementation (I2) Team.. He is also a member of the NCI-Centers for Medicare & Medicaid Services (CMS) Interagency Task Force, NCI Bioinformatics I2 Team, NCI Translational Research Working Group, NIH Multiple Principal Investigator Committee, NIH Bioengineering Consortium and the NIH Molecular Libraries and Molecular Imaging Roadmap Steering Committee. Dr. Sullivan is a member of the editorial board of Journal of the Academy of Molecular Imaging .
Dr. Sullivan received an A.B. in l966 from Brown University and an M.D. in 1970 from the University of Vermont College of Medicine. From 1970 to 1977, he held several postdoctoral training and fellowship appointments at the Bethesda Naval Hospital and Yale-New Haven Hospital . From 1977 to 1997, he held faculty positions at the Yale Medical School , Duke University Medical Center , and University of Pennsylvania Medical Center. In 1996, he was a member of the Project Hope Assessment Team that coordinated breast cancer detection and treatment in Poland .
